Search results
Results from the WOW.Com Content Network
For trans women this will typically involve taking oestrogen and anti-androgens, and for trans men taking testosterone. Oestrogen can promote breast growth and the redistribution of body fat.
Trans men can use barrier methods, oral contraceptives, IUDs, and other methods of contraception while taking testosterone. [37] Trans men must discontinue testosterone while attempting to conceive, while pregnant, and while breastfeeding, because high levels of testosterone during pregnancy can cause fetal abnormalities, specifically with the ...
5α-Reductase inhibitors like finasteride and dutasteride can be used to slow or prevent scalp hair loss and excessive body hair growth in transgender men taking testosterone. [33] However, they may also slow or reduce certain aspects of masculinization, such as facial hair growth, normal male-pattern body hair growth , and possibly clitoral ...
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
“Most trans people have a T dose that is less than 1mL at a time, whereas cis men who are on hormone replacement usually have a dose of 1mL every two weeks, which is why it is manufactured in ...
A transgender rights supporter takes part in a rally outside of the U.S. Supreme Court as the high court hears arguments in a case on transgender health rights on Dec. 4, 2024 in Washington, DC.
While trans men can become pregnant while taking testosterone, it is advised to stop before attempting to become pregnant, as taking testosterone during pregnancy can lead to issues with fetal development. [53] [54] Many trans men who have become pregnant were able to do so within six months of stopping testosterone. [55]
It found that less than 0.1% of U.S. transgender and gender diverse (TGD) adolescents were prescribed puberty blockers or gender-affirming hormones—and that not a single patient under age 12 ...